Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Venkata Jayanth Midde"'
Autor:
Naveena Aloysia D'Cor, Prashanth Siddaiah, Satyajit Mohapatra, Sangappa Malappa Dhaded, Padmavathi I V, Sonali Kar, Tripathi V N, Prasad Muley, Jugesh Chhatwal, Badri Narayan Patnaik, Emmanuel Vidor, Annick Moureau, Dhaval M Patel, Venkata Jayanth Midde, Sathish Reddy Jagga, Satyanarayana Peesapati, Fernando Noriega
Publikováno v:
PLoS ONE, Vol 18, Iss 8, p e0284898 (2023)
BackgroundPentavalent vaccines (DTP-HepB-Hib) have been introduced in many countries in their routine public immunization programmes to protect against diphtheria (D), tetanus (T), pertussis (P), hepatitis B (Hep B) and Hemophilus influenzae type b (
Externí odkaz:
https://doaj.org/article/4f64f3fa52cf43eeaefd9944e114ddba
Autor:
Lina Cordero De Los Santos, Jesús Feris-Iglesias, Naveena Aloysia D'Cor, Venkata Jayanth Midde, Badri Narayan Patnaik, Yaël Thollot, Anvar Rasuli, Eric Desauziers
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 6, Pp 1403-1411 (2018)
The Dominican Republic, historically non-endemic for cholera, is experiencing an ongoing cholera epidemic. We assessed the safety and immunogenicity of two doses of the killed bivalent (O1 and O139) whole-cell oral cholera vaccine (OCV) on day (D)0 a
Externí odkaz:
https://doaj.org/article/176e9bd9632e4220b9f9bfc3f173519e
Autor:
Leilani Sanchez, Supattra Rungmaitree, Pope Kosalaraksa, Watsamon Jantarabenjakul, Julie Leclercq, Yuvadee Yaiprayoon, Venkata Jayanth Midde, Kucku Varghese, Somnath Mangarule, Fernando Noriega
Publikováno v:
Pediatric Infectious Disease Journal.
Autor:
Naveena Aloysia D'Cor, Venkata Jayanth Midde, Jesús Feris-Iglesias, Yaël Thollot, Anvar Rasuli, Eric Desauziers, Lina Cordero De Los Santos, Badri Narayan Patnaik
Publikováno v:
Human Vaccines & Immunotherapeutics
The Dominican Republic, historically non-endemic for cholera, is experiencing an ongoing cholera epidemic. We assessed the safety and immunogenicity of two doses of the killed bivalent (O1 and O139) whole-cell oral cholera vaccine (OCV) on day (D)0 a